Blood Analyzer Discriminating White Blood Cells from Giant Platelets

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing blood analyzers struggle to accurately discriminate between white blood cells and giant platelets, particularly in specimens from patients with conditions like Bernard-Soulier syndrome or May-Hegglin anomaly, where giant platelets have a similar size to white blood cells, leading to inaccurate counting.

Innovation Solution

A blood analyzer method that involves preparing a measurement specimen by hemolyzing red blood cells and staining nucleic acids, using a reagent with a pH of 2.0 to 4.5 containing a surfactant, and detecting the intensity of side scattered light and fluorescence to differentiate white blood cells from giant platelets.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If forward scattered light intensity and fluorescence intensity are used for discrimination, then white blood cells can be identified, but giant platelets cannot be accurately distinguished from white blood cells

Engineering Contradiction:
Improvediscrimination accuracyVSAvoiddiscrimination information
Core Design Contradiction:
Measurement precisionVSLoss of information

Solution Approach 1:

The invention adds side scattered light intensity as a new dimension to the discrimination process. Previously, only forward scattered light intensity and fluorescence intensity were used, creating a two-dimensional discrimination space where giant platelets and white blood cells overlapped. By introducing side scattered light intensity, the system creates a three-dimensional discrimination space that provides additional separation between these cell types, enabling accurate identification of giant platelets that were previously indistinguishable from white blood cells.

Inventive Principle:
Principle #17Another dimension (Dimensionality change)

2Reliability

If a reagent with pH 2.0 to 4.5 containing surfactant is used, then measurement specimen preparation is improved, but the complexity of reagent formulation increases

Engineering Contradiction:
Improvemeasurement reliabilityVSAvoidreagent formulation complexity
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The invention specifies a particular pH range (2.0 to 4.5) for the reagent, which is more acidic than conventional reagents. This parameter change, combined with the addition of surfactant, improves the lysis of red blood cells and the release of intracellular contents, thereby enhancing measurement reliability. The specific pH parameter optimization ensures consistent and reliable specimen preparation while maintaining reagent stability.

Inventive Principle:
Principle #35Parameter changes

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This approach enables accurate discrimination and counting of white blood cells, even in specimens containing giant platelets, by utilizing the differences in side scattered light and fluorescence intensities, thereby improving the accuracy of blood cell analysis.

Implementation Method 1

a hemolytic agent that hemolyzes red blood cells

Methodology Applied
Scientific EffectHemolysis:

Implementation Method 2

a staining reagent that stains nucleic acids; detecting intensity of side scattered light and intensity of fluorescence generated from the measurement specimen

Methodology Applied
Scientific EffectFluorescence: Fluorescence

Implementation Method 3

applying light onto the measurement specimen flowing through the flow cell, and detects forward scattered light and fluorescence generated from the measurement specimen

Methodology Applied
Scientific EffectLight scattering: Scattering

Data Source

PatentEP3141885B1Blood analyzer
Publication Date: 2023.05.10 SYSMEX CORP
  • EP3141885B1 patent drawingFigure 1
  • EP3141885B1 patent drawingFigure 2
  • EP3141885B1 patent drawingFigure 3

AI summary

Disclosed is a blood analyzer comprising: a specimen preparation unit that prepares a measurement specimen by mixing a hemolytic agent that hemolyzes red blood cells, a staining dye that dyes nucleic acids, and a blood specimen; a detector that detects intensity of side scattered light and intensity of fluorescence generated with application of light from the measurement specimen prepared by the specimen preparation unit; and an analysis unit that discriminates white blood cells from giant platelets based on the intensity of side scattered light and the intensity of fluorescence detected by the detector, and counts the white blood cells.